Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion.

Yao, Chih-Chien

Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion. [electronic resource] - Journal of gastroenterology and hepatology May 2015 - 918-24 p. digital

Publication Type: Journal Article

1440-1746

10.1111/jgh.12874 doi


Adult
Aging--immunology
Antiviral Agents--therapeutic use
Consolidation Chemotherapy
Female
Follow-Up Studies
Forecasting
Hepatitis B--drug therapy
Hepatitis B e Antigens--blood
Humans
Lamivudine--therapeutic use
Male
Middle Aged
Molecular Sequence Data
Nucleotides--immunology
Recurrence
Retrospective Studies
Risk
Seroconversion
Time Factors
Young Adult